These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17278492)

  • 21. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer.
    De Meerleer GO; Villeirs GM; Vakaet L; Delrue LJ; De Neve WJ
    Strahlenther Onkol; 2004 Sep; 180(9):573-81. PubMed ID: 15378188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
    Song W; Battista J; Van Dyk J
    Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors.
    Soisson ET; Tomé WA; Richards GM; Mehta MP
    Radiother Oncol; 2006 Mar; 78(3):313-21. PubMed ID: 16490269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A feasible application of constrained optimization in the IMRT system.
    Artacho Terrer JM; Nasarre Benedé MA; Bernués del Rio E; Cruz Llanas S
    IEEE Trans Biomed Eng; 2007 Mar; 54(3):370-9. PubMed ID: 17355048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription dose in permanent (131)Cs seed prostate implants.
    Yue N; Heron DE; Komanduri K; Huq MS
    Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
    Gordon JJ; Sayah N; Weiss E; Siebers JV
    Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated radiotherapy for favorable risk prostate cancer.
    Rene N; Faria S; Cury F; David M; Duclos M; Shenouda G; Souhami L
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):805-10. PubMed ID: 20510194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-fraction dose delivery timing during stereotactic radiotherapy can influence the radiobiological effect.
    Murphy MJ; Lin PS; Ozhasoglu C
    Med Phys; 2007 Feb; 34(2):481-4. PubMed ID: 17388164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear medicine dosimetry.
    Stabin M
    Phys Med Biol; 2006 Jul; 51(13):R187-202. PubMed ID: 16790903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of radiobiological effects in intensity modulated proton therapy.
    Wilkens JJ; Oelfke U
    Med Phys; 2005 Feb; 32(2):455-65. PubMed ID: 15789592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose volume histogram comparison between ADAC Pinnacle and Nomos Corvus systems for IMRT.
    Ayyangar KM; Fung AY; Li S; Pillai S; Yoe-Sein MM; Zhen W; Enke CA
    Australas Phys Eng Sci Med; 2005 Mar; 28(1):1-7. PubMed ID: 15920983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W; Li J; Ma CM
    Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helical tomotherapy-based STAT RT: Dosimetric evaluation for clinical implementation of a rapid radiation palliation program.
    McIntosh A; Dunlap N; Sheng K; Geezey C; Turner B; Blackhall L; Weiss G; Lappinen E; Larner JM; Read PW
    Med Dosim; 2010; 35(4):280-6. PubMed ID: 19944589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast multifield optimization of the biological effect in ion therapy.
    Wilkens JJ; Oelfke U
    Phys Med Biol; 2006 Jun; 51(12):3127-40. PubMed ID: 16757867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RapidArc radiotherapy planning for prostate cancer: single-arc and double-arc techniques vs. intensity-modulated radiotherapy.
    Sze HC; Lee MC; Hung WM; Yau TK; Lee AW
    Med Dosim; 2012; 37(1):87-91. PubMed ID: 21925863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
    van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment simulation approaches for the estimation of the distributions of treatment quality parameters generated by geometrical uncertainties.
    Baum C; Alber M; Birkner M; Nüsslin F
    Phys Med Biol; 2004 Dec; 49(24):5475-88. PubMed ID: 15724537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy.
    Nutting CM; Corbishley CM; Sanchez-Nieto B; Cosgrove VP; Webb S; Dearnaley DP
    Br J Radiol; 2002 Feb; 75(890):151-61. PubMed ID: 11893639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.